AVROBIO (AVRO) Stock Chart & Stock Price History → Trump conviction scandal exposed (From Porter & Company) (Ad) Free AVRO Stock Alerts $1.48 +0.04 (+2.78%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AVROBIO Stock Price Performance5 Day Performance-1.99%1 Month Performance+21.31%3 Month Performance+11.28%6 Month Performance+14.73%Year-To-Date Performance+8.82%1 Year Performance+38.32% Receive AVRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AVROBIO and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. AVRO Stock Chart for Saturday, June, 1, 2024 AVRO Chart by TradingView AVROBIO Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$1.44$1.48+2.78%$1.49$1.44235,336 shs$66.44 million05/30/2024$1.47$1.44-2.04%$1.49$1.4487,383 shs$64.64 million05/29/2024$1.49$1.47-1.34%$1.49$1.42239,854 shs$65.99 million05/28/2024$1.51$1.49-1.32%$1.54$1.47141,639 shs$66.89 million05/27/2024$1.51$1.51$1.51$1.45679,300 shs$67.78 million05/24/2024$1.41$1.51+7.09%$1.51$1.45679,346 shs$67.78 million Get the Latest News and Ratings for AVRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AVROBIO and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$1.40$1.41+0.71%$1.48$1.37302,509 shs$63.30 million05/22/2024$1.38$1.40+1.45%$1.40$1.36111,622 shs$62.85 million05/21/2024$1.39$1.38-0.72%$1.40$1.36124,699 shs$61.95 million05/20/2024$1.39$1.39$1.40$1.3791,224 shs$62.40 million05/17/2024$1.39$1.39$1.41$1.33548,745 shs$62.40 million05/16/2024$1.37$1.39+1.46%$1.39$1.32170,771 shs$62.40 million05/15/2024$1.29$1.37+6.20%$1.38$1.24583,940 shs$61.50 million05/14/2024$1.35$1.29-4.44%$1.34$1.26562,063 shs$57.91 million05/13/2024$1.23$1.35+9.76%$1.37$1.22860,922 shs$60.60 million05/10/2024$1.25$1.23-1.60%$1.26$1.22242,716 shs$55.18 million05/09/2024$1.26$1.25-0.79%$1.27$1.2430,702 shs$56.08 million05/08/2024$1.25$1.26+0.80%$1.26$1.23146,294 shs$56.52 million05/07/2024$1.24$1.25+0.81%$1.27$1.23224,786 shs$56.08 million05/06/2024$1.22$1.24+1.64%$1.25$1.21156,514 shs$55.63 million05/03/2024$1.23$1.22-0.81%$1.24$1.18202,097 shs$54.73 million05/02/2024$1.22$1.23+0.82%$1.25$1.21473,059 shs$55.18 million05/01/2024$1.19$1.22+2.52%$1.22$1.17398,885 shs$54.73 million04/30/2024$1.19$1.19$1.22$1.19470,501 shs$53.38 million04/29/2024$1.21$1.19-1.65%$1.21$1.18142,738 shs$53.39 million04/26/2024$1.19$1.21+2.11%$1.22$1.18204,967 shs$54.28 million04/25/2024$1.19$1.19-0.42%$1.20$1.1795,454 shs$53.16 million04/24/2024$1.21$1.19-1.65%$1.21$1.19348,448 shs$53.38 million04/23/2024$1.20$1.21+0.83%$1.23$1.1853,884 shs$54.28 million04/22/2024$1.20$1.20$1.22$1.1852,538 shs$53.83 million04/19/2024$1.24$1.20-3.23%$1.23$1.2039,507 shs$53.83 million04/18/2024$1.22$1.24+1.64%$1.26$1.2236,515 shs$55.63 million04/17/2024$1.26$1.22-3.17%$1.27$1.20203,387 shs$54.73 million04/16/2024$1.26$1.26$1.27$1.24183,989 shs$56.52 million04/15/2024$1.27$1.26-0.79%$1.28$1.24203,318 shs$56.53 million04/12/2024$1.27$1.27$1.29$1.2456,543 shs$56.97 million04/11/2024$1.25$1.27+1.60%$1.29$1.25140,913 shs$56.97 million04/10/2024$1.26$1.25-0.79%$1.27$1.2481,039 shs$56.08 million04/09/2024$1.26$1.26$1.28$1.2492,274 shs$56.52 million04/08/2024$1.27$1.26-0.79%$1.27$1.23107,823 shs$56.52 millionThe #1 Crypto That You Don’t Own… Yet (Ad)There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details…04/05/2024$1.31$1.27-3.05%$1.31$1.2683,205 shs$56.97 million04/04/2024$1.30$1.31+0.77%$1.31$1.27160,282 shs$58.77 million04/03/2024$1.28$1.30+1.56%$1.31$1.26155,865 shs$58.32 million04/02/2024$1.28$1.28$1.29$1.22135,543 shs$57.42 million04/01/2024$1.28$1.28$1.30$1.2659,242 shs$57.42 million03/29/2024$1.28$1.28$1.30$1.25104,197 shs$57.42 million03/28/2024$1.26$1.28+1.59%$1.30$1.25104,197 shs$57.42 million03/27/2024$1.26$1.26$1.27$1.22423,615 shs$56.52 million03/26/2024$1.22$1.26+3.28%$1.27$1.2369,151 shs$56.52 million03/25/2024$1.28$1.22-4.69%$1.25$1.15812,323 shs$54.73 million03/22/2024$1.25$1.28+2.40%$1.29$1.2346,202 shs$57.42 million03/21/2024$1.28$1.25-2.34%$1.28$1.2377,122 shs$56.08 million03/20/2024$1.26$1.28+1.59%$1.29$1.24183,970 shs$57.42 million03/19/2024$1.29$1.26-2.33%$1.30$1.2659,161 shs$56.52 million03/18/2024$1.30$1.29-0.77%$1.30$1.27301,725 shs$57.50 million03/15/2024$1.27$1.30+2.36%$1.31$1.20493,518 shs$57.94 million03/14/2024$1.29$1.27-1.55%$1.29$1.25119,358 shs$56.60 million03/13/2024$1.28$1.29+0.78%$1.30$1.25176,659 shs$57.50 million03/12/2024$1.30$1.28-1.54%$1.32$1.27112,495 shs$57.05 million03/11/2024$1.31$1.30-0.76%$1.32$1.26165,003 shs$57.94 million03/08/2024$1.31$1.31$1.33$1.2858,864 shs$58.39 million03/07/2024$1.34$1.31-2.24%$1.34$1.28365,885 shs$58.39 million03/06/2024$1.30$1.34+3.08%$1.34$1.2782,870 shs$59.72 million03/05/2024$1.31$1.30-0.76%$1.33$1.2745,831 shs$57.94 million03/04/2024$1.33$1.31-1.50%$1.35$1.20125,856 shs$58.39 million03/01/2024$1.31$1.33+1.53%$1.36$1.29178,017 shs$59.28 million02/29/2024$1.32$1.31-0.76%$1.33$1.30164,020 shs$58.39 million Related Companies: Black Diamond Therapeutics Stock Chart Adaptimmune Therapeutics Stock Chart Candel Therapeutics Stock Chart Metagenomi Stock Chart Innate Pharma Stock Chart Genfit Stock Chart Zura Bio Stock Chart Compugen Stock Chart Coherus BioSciences Stock Chart Monte Rosa Therapeutics Stock Chart Receive AVRO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AVROBIO and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVRO) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVROBIO, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.